A Clinical and Animal Experiment Integrated Platform for Small-Molecule Screening Reveals Potential Targets of Bioactive Compounds from a Herbal Prescription Based on the Therapeutic Efficacy of Yinchenhao Tang for Jaundice Syndrome

A herbal prescription in traditional Chinese medicine (TCM) has great complexity, with multiple components and multiple targets, making it extremely challenging to determine its bioactive compounds. Yinchenhao Tang (YCHT) has been extensively used for the treatment of jaundice disease. Although many...

Full description

Bibliographic Details
Main Authors: Hui Xiong, Ai-Hua Zhang, Ya-Jing Guo, Xiao-Hang Zhou, Hui Sun, Le Yang, Heng Fang, Guang-Li Yan, Xi-Jun Wang
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Engineering
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2095809921000527
_version_ 1818913669982978048
author Hui Xiong
Ai-Hua Zhang
Ya-Jing Guo
Xiao-Hang Zhou
Hui Sun
Le Yang
Heng Fang
Guang-Li Yan
Xi-Jun Wang
author_facet Hui Xiong
Ai-Hua Zhang
Ya-Jing Guo
Xiao-Hang Zhou
Hui Sun
Le Yang
Heng Fang
Guang-Li Yan
Xi-Jun Wang
author_sort Hui Xiong
collection DOAJ
description A herbal prescription in traditional Chinese medicine (TCM) has great complexity, with multiple components and multiple targets, making it extremely challenging to determine its bioactive compounds. Yinchenhao Tang (YCHT) has been extensively used for the treatment of jaundice disease. Although many studies have examined the efficacy and active ingredients of YCHT, there is still a lack of an in-depth systematic analysis of its effective components, mechanisms, and potential targets—especially one based on clinical patients. This study established an innovative strategy for discovering the potential targets and active compounds of YCHT based on an integrated clinical and animal experiment platform. The serum metabolic profiles and constituents of YCHT in vivo were determined by ultra-performance liquid chromatography–quadrupole time-of-flight mass spectrometry (UPLC-Q-ToF-MS)-based metabolomics combined with a serum pharmacochemistry method. Moreover, a compound–target–pathway network was constructed and analyzed by network pharmacology and ingenuity pathway analysis (IPA). We found that eight active components could modulate five key targets. These key targets were further verified by enzyme-linked immunosorbent assay (ELISA), which indicated that YCHT exerts therapeutic effects by targeting cholesterol 7α-hydroxylase (CYP7A1), multidrug-resistance-associated protein 2 (ABCC2), multidrug-resistance-associated protein 3 (ABCC3), uridine diphosphate glucuronosyl transferase 1A1 (UGT1A1), and farnesoid X receptor (FXR), and by regulating metabolic pathways including primary bile acid biosynthesis, porphyrin and chlorophyll metabolism, and biliary secretion. Eight main effective compounds were discovered and correlated with the key targets and pathways. In this way, we demonstrate that this integrated strategy can be successfully applied for the effective discovery of the active compounds and therapeutic targets of an herbal prescription.
first_indexed 2024-12-19T23:34:10Z
format Article
id doaj.art-38538fe076fe48908e9167586e4c8ed5
institution Directory Open Access Journal
issn 2095-8099
language English
last_indexed 2024-12-19T23:34:10Z
publishDate 2021-09-01
publisher Elsevier
record_format Article
series Engineering
spelling doaj.art-38538fe076fe48908e9167586e4c8ed52022-12-21T20:01:40ZengElsevierEngineering2095-80992021-09-017912931305A Clinical and Animal Experiment Integrated Platform for Small-Molecule Screening Reveals Potential Targets of Bioactive Compounds from a Herbal Prescription Based on the Therapeutic Efficacy of Yinchenhao Tang for Jaundice SyndromeHui Xiong0Ai-Hua Zhang1Ya-Jing Guo2Xiao-Hang Zhou3Hui Sun4Le Yang5Heng Fang6Guang-Li Yan7Xi-Jun Wang8National Chinmedomics Research Center & National TCM Key Laboratory of Serum Pharmacochemistry, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin 150040, ChinaNational Chinmedomics Research Center & National TCM Key Laboratory of Serum Pharmacochemistry, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin 150040, ChinaNational Chinmedomics Research Center & National TCM Key Laboratory of Serum Pharmacochemistry, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin 150040, ChinaNational Chinmedomics Research Center & National TCM Key Laboratory of Serum Pharmacochemistry, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin 150040, ChinaNational Chinmedomics Research Center & National TCM Key Laboratory of Serum Pharmacochemistry, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin 150040, ChinaNational Chinmedomics Research Center & National TCM Key Laboratory of Serum Pharmacochemistry, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin 150040, ChinaNational Chinmedomics Research Center & National TCM Key Laboratory of Serum Pharmacochemistry, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin 150040, ChinaNational Chinmedomics Research Center & National TCM Key Laboratory of Serum Pharmacochemistry, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin 150040, ChinaNational Chinmedomics Research Center & National TCM Key Laboratory of Serum Pharmacochemistry, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin 150040, China; State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau 999078, China; National Engineering Laboratory for the Development of Southwestern Endangered Medicinal Materials, Guangxi Botanical Garden of Medicinal Plant, Nanning 530023, China; Corresponding author.A herbal prescription in traditional Chinese medicine (TCM) has great complexity, with multiple components and multiple targets, making it extremely challenging to determine its bioactive compounds. Yinchenhao Tang (YCHT) has been extensively used for the treatment of jaundice disease. Although many studies have examined the efficacy and active ingredients of YCHT, there is still a lack of an in-depth systematic analysis of its effective components, mechanisms, and potential targets—especially one based on clinical patients. This study established an innovative strategy for discovering the potential targets and active compounds of YCHT based on an integrated clinical and animal experiment platform. The serum metabolic profiles and constituents of YCHT in vivo were determined by ultra-performance liquid chromatography–quadrupole time-of-flight mass spectrometry (UPLC-Q-ToF-MS)-based metabolomics combined with a serum pharmacochemistry method. Moreover, a compound–target–pathway network was constructed and analyzed by network pharmacology and ingenuity pathway analysis (IPA). We found that eight active components could modulate five key targets. These key targets were further verified by enzyme-linked immunosorbent assay (ELISA), which indicated that YCHT exerts therapeutic effects by targeting cholesterol 7α-hydroxylase (CYP7A1), multidrug-resistance-associated protein 2 (ABCC2), multidrug-resistance-associated protein 3 (ABCC3), uridine diphosphate glucuronosyl transferase 1A1 (UGT1A1), and farnesoid X receptor (FXR), and by regulating metabolic pathways including primary bile acid biosynthesis, porphyrin and chlorophyll metabolism, and biliary secretion. Eight main effective compounds were discovered and correlated with the key targets and pathways. In this way, we demonstrate that this integrated strategy can be successfully applied for the effective discovery of the active compounds and therapeutic targets of an herbal prescription.http://www.sciencedirect.com/science/article/pii/S2095809921000527EfficacyBioactive compoundSmall moleculeTargetsHerbal medicineMetabolomics
spellingShingle Hui Xiong
Ai-Hua Zhang
Ya-Jing Guo
Xiao-Hang Zhou
Hui Sun
Le Yang
Heng Fang
Guang-Li Yan
Xi-Jun Wang
A Clinical and Animal Experiment Integrated Platform for Small-Molecule Screening Reveals Potential Targets of Bioactive Compounds from a Herbal Prescription Based on the Therapeutic Efficacy of Yinchenhao Tang for Jaundice Syndrome
Engineering
Efficacy
Bioactive compound
Small molecule
Targets
Herbal medicine
Metabolomics
title A Clinical and Animal Experiment Integrated Platform for Small-Molecule Screening Reveals Potential Targets of Bioactive Compounds from a Herbal Prescription Based on the Therapeutic Efficacy of Yinchenhao Tang for Jaundice Syndrome
title_full A Clinical and Animal Experiment Integrated Platform for Small-Molecule Screening Reveals Potential Targets of Bioactive Compounds from a Herbal Prescription Based on the Therapeutic Efficacy of Yinchenhao Tang for Jaundice Syndrome
title_fullStr A Clinical and Animal Experiment Integrated Platform for Small-Molecule Screening Reveals Potential Targets of Bioactive Compounds from a Herbal Prescription Based on the Therapeutic Efficacy of Yinchenhao Tang for Jaundice Syndrome
title_full_unstemmed A Clinical and Animal Experiment Integrated Platform for Small-Molecule Screening Reveals Potential Targets of Bioactive Compounds from a Herbal Prescription Based on the Therapeutic Efficacy of Yinchenhao Tang for Jaundice Syndrome
title_short A Clinical and Animal Experiment Integrated Platform for Small-Molecule Screening Reveals Potential Targets of Bioactive Compounds from a Herbal Prescription Based on the Therapeutic Efficacy of Yinchenhao Tang for Jaundice Syndrome
title_sort clinical and animal experiment integrated platform for small molecule screening reveals potential targets of bioactive compounds from a herbal prescription based on the therapeutic efficacy of yinchenhao tang for jaundice syndrome
topic Efficacy
Bioactive compound
Small molecule
Targets
Herbal medicine
Metabolomics
url http://www.sciencedirect.com/science/article/pii/S2095809921000527
work_keys_str_mv AT huixiong aclinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT aihuazhang aclinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT yajingguo aclinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT xiaohangzhou aclinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT huisun aclinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT leyang aclinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT hengfang aclinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT guangliyan aclinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT xijunwang aclinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT huixiong clinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT aihuazhang clinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT yajingguo clinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT xiaohangzhou clinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT huisun clinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT leyang clinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT hengfang clinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT guangliyan clinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT xijunwang clinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome